IGF-II Producing Hepatocellular Carcinoma Treated with Sorafenib: Metabolic Complications and a Foresight to Molecular Targeting Therapy to the IGF Signal

Hypoglycemia is a rare paraneoplastic manifestation of patients with neoplasms. Hypoglycemia can be induced by several causes, including an aberrant increase of hypoglycemic agents and adrenal insufficiency. Sorafenib is the first agent to demonstrate a survival benefit in the treatment of advanced...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Okushin, Kazuya, Asaoka, Yoshinari, Fukuda, Izumi, Fujiwara, Naoto, Minami, Tatsuya, Sato, Masaya, Mikami, Shintaro, Uchino, Koji, Enooku, Kenichiro, Kondo, Yuji, Tateishi, Ryosuke, Goto, Tadashi, Shiina, Shuichiro, Yoshida, Haruhiko, Koike, Kazuhiko
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2012
Assuntos:
Published online: December, 2012
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3551420/
https://ncbi.nlm.nih.gov/pubmed/23341802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000346462
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados